4.7 Article

Systemic lupus erythematosus onset in lupus-prone B6.MRL/lpr mice Is influenced by weight gain and Is preceded by an increase in neutrophil oxidative burst activity

Journal

FREE RADICAL BIOLOGY AND MEDICINE
Volume 86, Issue -, Pages 362-373

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2015.06.005

Keywords

Systemic lupus erythematosus; Obesity; Reactive oxygen species; Oxidative stress; Neutrophil; Antinuclear antibody

Funding

  1. National Council for Scientific and Technological Development (CNPq) [141691/2014-0]
  2. Coordination for the Improvement of Higher Education Personnel (CAPES)

Ask authors/readers for more resources

In this study, we assessed whether weight gain influenced the systemic lupus erythemalosus (SLE) onset and/or outcome, and examined the role that reactive oxygen species (ROS) production by neutrophils played in the SCE onset and/or outcome. Female control (C57BL/6) and lupus prone B6.MRL/lpr mice (CM and LPM, respectively) at 4 weeks old were fed standard diet or standard diet plus cafeteria diet during 12 weeks. SCE diagnosis relied on the presence of both antinuclear antibodies (ANA) and renal abnormalities. We found that the percentage of weight gain in CM and LPM increased as a function of the length of cafeteria diet feeding period, but it was not associated with energy intake. Cafeteria diet fed CM and LPM at 8 and 12 weeks old were overweight, while CM and LPM at 16 weeks old were obese. Compared with standard diet fed CM and LPM, cafeteria diet fed CM and LPM exhibited elevated glucose and total cholesterol levels, and diminished triglycerides levels. Standard diet fed 16-week-old LPM and cafeteria diet fed 12-week-old LPM had nephritis, characterized by the increased interstitial infiltration of leukocytes. Cafeteria diet induced weight gain rose the frequency of homogeneous and speckled ANA staining patterns in the 12- and 16-week-old LPM groups. Together, these results indicated that weight gain anticipated the SLE onset. In addition, neutrophils from cafeteria diet fed 8-week-old LPM exhibited augmented ROS production capacity; in standard diet fed LPM, such rise occurred only in the 16-week-old group. Thus, the neutrophil ROS production capacity was increased before the SLE onset and during its outcome. Overweight and obese CM and LPM displayed elevated levels of kidney, liver, heart, and spleen lipid peroxidation. In conclusion, cafeteria diet-induced weight gain is associated with the increased production of ANA and neutrophil-derived ROS, which may contribute to accelerate the SLE onset. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Environmental Sciences

Toxicity of spike fragments SARS-CoV-2 S protein for zebrafish: A tool to study its hazardous for human health?

Bianca H. Ventura Fernandes, Natalia Martins Feitosa, Ana Paula Barbosa, Camila Gasque Bomfim, Anali M. B. Garnique, Ivana F. Rosa, Maira S. Rodrigues, Lucas B. Doretto, Daniel F. Costa, Bruno Camargo-dos-Santos, Gabrielli A. Franco, Joao Favero Neto, Juliana Sartori Lunardi, Marina Sanson Bellot, Nina Pacheco Capelini Alves, Camila C. Costa, Mayumi F. Aracati, Leticia F. Rodrigues, Rafaela Hemily Cirilo, Raul Marcelino Colagrande, Francisco I. F. Gomes, Rafael T. Nakajima, Marco A. A. Belo, Percilia Cardoso Giaquinto, Susana Luporini de Oliveira, Silas Fernandes Eto, Dayanne Carla Fernandes, Wilson G. Manrique, Gabriel Conde, Roberta R. C. Rosales, Iris Todeschini, Ilo Rivero, Edgar Llontop, German G. Sgro, Gabriel Umaji Oka, Natalia Fernanda Bueno, Fausto K. Ferraris, Mariana T. Q. de Magalhaes, Renata J. Medeiros, Juliana M. Mendonca-Gomes, Mara Souza Junqueira, Katia Conceicao, Leticia Gomes de Pontes, Antonio Condino-Neto, Andrea C. Perez, Leonardo J. G. Barcellos, Jose Dias Correa Junior, Erick Gustavo Dorlass, Niels O. S. Camara, Edison Luiz Durigon, Fernando Q. Cunha, Rafael H. Nobrega, Glaucia M. Machado-Santelli, Chuck S. Farah, Flavio P. Veras, Jorge Galindo-Villegas, Leticia Costa-Lotufo, Thiago M. Cunha, Roger Chammas, Luciani R. Carvalho, Cristiane R. Guzzo, Guilherme Malafaia, Ives Charlie-Silva

Summary: This study found that injection of SARS-CoV-2 Spike protein rSpike in zebrafish resulted in mortality and adverse effects on liver, kidney, ovary, and brain tissues, with a survival rate of 78.6%. The conserved genetic homology between zebrafish and humans may contribute to the intense toxic effects observed. The results highlight the potential of zebrafish as an animal model for translational COVID-19 research and for understanding ecotoxicological impacts, vaccine responses, and therapeutic approaches.

SCIENCE OF THE TOTAL ENVIRONMENT (2022)

Article Cell Biology

SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients

Marjorie C. Pontelli, Italo A. Castro, Ronaldo B. Martins, Leonardo La Serra, Flavio P. Veras, Daniele C. Nascimento, Camila M. Silva, Ricardo S. Cardoso, Roberta Rosales, Rogerio Gomes, Thais M. Lima, Juliano P. Souza, Brenda C. Vitti, Diego B. Caetite, Mikhael H. F. de Lima, Spencer D. Stumpf, Cassandra E. Thompson, Louis-Marie Bloyet, Juliana E. Toller-Kawahisa, Marcela C. Giannini, Leticia P. Bonjorno, Maria I. F. Lopes, Sabrina S. Batah, Li Siyuan, Rodrigo Luppino-Assad, Sergio C. L. Almeida, Fabiola R. Oliveira, Maira N. Benatti, Lorena L. F. Pontes, Rodrigo C. Santana, Fernando C. Vilar, Maria Auxiliadora-Martins, Pei-Yong Shi, Thiago M. Cunha, Rodrigo T. Calado, Jose C. Alves-Filho, Dario S. Zamboni, Alexandre T. Fabro, Paulo Louzada-Junior, Rene D. R. Oliveira, Sean P. J. Whelan, Fernando Q. Cunha, Eurico Arruda

Summary: SARS-CoV-2 infection can lead to lymphocytopenia and infect immune cells such as monocytes, B cells, and T cells, resulting in T cell apoptosis. Additionally, SARS-CoV-2 is frequently detected in monocytes and B cells from COVID-19 patients.

JOURNAL OF MOLECULAR CELL BIOLOGY (2022)

Article Cell Biology

Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions

Laura Brandolini, Michele d'Angelo, Rubina Novelli, Vanessa Castelli, Cristina Giorgio, Anna Sirico, Pasquale Cocchiaro, Francesco D'Egidio, Elisabetta Benedetti, Claudia Cristiano, Antonella Bugatti, Anna Ruocco, Pier Giorgio Amendola, Carmine Talarico, Candida Manelfi, Daniela Iaconis, Andrea Beccari, Andreza U. Quadros, Thiago M. Cunha, Arnaldo Caruso, Roberto Russo, Annamaria Cimini, Andrea Aramini, Marcello Allegretti

Summary: This study discovered that paclitaxel can bind and activate C5a receptor 1 (C5aR1), which is crucial in the development of chemotherapy-induced peripheral neuropathy (CIPN) and hypersensitivity reactions (HSRs). In vitro studies and animal experiments confirmed the effectiveness of C5aR1 inhibition in protecting against neuropathological effects and reducing CIPN symptoms. Additionally, C5aR1 inhibition can counteract paclitaxel-induced hypersensitivity reactions. Thus, C5aR1 is identified as a potential pharmacological target for the prevention and treatment of CIPN and HSRs induced by paclitaxel.

CELL DEATH & DISEASE (2022)

Article Immunology

Tumour necrosis factor plays a deleterious role in the pathogenesis of chikungunya virus infection

Thaiane Pinto Moreira, Carla Daiane Ferreira de Sousa, Victor Rodrigues de Melo Costa, Celso Martins Queiroz-Junior, Franciele Martins Santos, Caio Santos Bonilha, Lisia Maria Esper, Mauricio Lacerda Nogueira, Thiago Mattar Cunha, Mauro Martins Teixeira, Vivian Vasconcelos Costa, Daniele da Gloria de Souza

Summary: This study describes a novel mouse model of CHIKV infection and evaluates the role of tumour necrosis factor in the disease's pathogenesis. It shows that TNF plays a dual role in viral clearance and driving tissue damage and hypernociception. Therefore, TNF inhibitors may have therapeutic benefits, but viral levels must be monitored and used in combination with antiviral drugs when treating CHIKV-infected patients.

IMMUNOLOGY (2023)

Article Multidisciplinary Sciences

Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection

Leticia de Almeida, Alexandre L. N. da Silva, Tamara S. Rodrigues, Samuel Oliveira, Adriene Y. Ishimoto, Amanda A. Seribelli, Amanda Becerra, Warrison A. Andrade, Marco A. Ataide, Camila C. S. Caetano, Keyla S. G. de Sa, Natalia Pelisson, Ronaldo B. Martins, Juliano de Paula Souza, Eurico Arruda, Sabrina S. Batah, Ricardo Castro, Fabiani G. Frantz, Fernando Q. Cunha, Thiago M. Cunha, Alexandre T. Fabro, Larissa D. Cunha, Paulo Louzada-Junior, Rene D. R. de Oliveira, Dario S. Zamboni

Summary: This study identifies niclosamide as a potential FDA-approved drug for treating COVID-19 by inhibiting inflammasome activation and SARS-CoV-2 replication. Niclosamide shows strong inhibitory effects on inflammasome activation in human monocytes and PBMCs from COVID-19 patients in vitro, as well as in an in vivo mouse model of SARS-CoV-2 infection.

SCIENCE ADVANCES (2022)

Article Cell Biology

Impact of Microbiota Depletion by Antibiotics on SARS-CoV-2 Infection of K18-hACE2 Mice

Patricia Brito Rodrigues, Giovanni Freitas Gomes, Monara K. S. C. Angelim, Gabriela F. Souza, Stefanie Primon Muraro, Daniel A. Toledo-Teixeira, Bruna Amanda Cruz Rattis, Amanda Stephane Passos, Lais Passarielo Pral, Vinicius de Rezende Rodovalho, Arilson Bernardo dos Santos P. Gomes, Valquiria Aparecida Matheus, Andre Saraiva Leao Marcelo Antunes, Fernanda Crunfli, Krist Helen Antunes, Ana Paula Duarte de Souza, Silvio Roberto Consonni, Luiz Osorio Leiria, Jose Carlos Alves-Filho, Thiago M. Cunha, Pedro M. M. Moraes-Vieira, Jose Luiz Proenca-Modena, Marco Aurelio R. Vinolo

Summary: Clinical and experimental data suggest that SARS-CoV-2 infection leads to changes in gut microbiota. However, the relevance of these changes remains unclear. This study examined the impact of microbiota depletion on the clinical and immunological responses of mice to SARS-CoV-2 infection. The results showed that microbiota depletion had no effect on the infection.

CELLS (2022)

Article Cell Biology

FK506 impairs neutrophil migration that results in increased polymicrobial sepsis susceptibility

Vanessa de Fatima Borges, Leticia Selinger Galant, Alexandre Kanashiro, Fernanda Vargas e Silva Castanheira, Valter Vinicius Silva Monteiro, Diego angelo Duarte, Filipe Camargo Rodrigues, Camila Meirelles de Souza Silva, Ayda Henriques Schneider, Guilherme Cesar Martelossi Cebinelli, Mikhael Haruo Fernandes de Lima, Joao Paulo de Biaso Viola, Thiago Mattar Cunha, Claudio Miguel da Costa Neto, Jose Carlos Farias Alves-Filho, Andre Sampaio Pupo, Fernando de Queiroz Cunha

Summary: This study investigated the effects of FK506 on sepsis immunopathology and found that FK506 treatment resulted in failed neutrophil migration, leading to increased bacteremia and systemic inflammatory response, causing higher organ damage and mortality rates.

INFLAMMATION RESEARCH (2023)

Article Cell Biology

PI3Kγ controls IL-17A expression and attenuates alveolar bone loss in an experimental periodontitis model

Marcelo Franchin, Thaise Mayumi Taira, Douglas da Silva Prado, Cesar Augusto Speck Hernandez, Fabio Bonifacio de Andrade, Henrique Ballassini Abdalla, Marcelo Henrique Napimoga, Thiago Mattar Cunha, Sandra Yasuyo Fukada, Pedro Luiz Rosalen

Summary: In this study, we investigated the modulatory effects of PI3K gamma on IL-17A expression and the progression of experimental periodontitis in vivo. Our results showed that PI3K gamma inhibitor can attenuate alveolar bone loss and downregulate IL-17A and Rankl gene expression.

INFLAMMATION RESEARCH (2023)

Article Infectious Diseases

The nociceptive response induced by different classes of Tityus serrulatus neurotoxins: The important role of Ts5 in venom-induced nociception

Felipe Cerni, Isadora Oliveira, Francielle Cordeiro, Karla Bordon, Isabela Ferreira, Wuelton Monteiro, Eliane Arantes, Thiago Cunha, Manuela Pucca

Summary: This study evaluated the pain behavior induced by T. serrulatus venom and its isolated neurotoxins in mice, and found that different neurotoxins caused varying degrees of pain behavior. Additionally, the researchers developed a mice-derived polyclonal antibody targeting Ts5, which was able to neutralize the effect of this neurotoxin and significantly reduce the nociception produced by the whole venom. This study is the first to explore the effects of different classes of T. serrulatus neurotoxins on nociception, and demonstrates the important role of Ts5 in scorpion sting-induced pain.

PLOS NEGLECTED TROPICAL DISEASES (2023)

Article Pharmacology & Pharmacy

Brief research report: Repurposing pentoxifylline to treat intense acute swimming-Induced delayed-onset muscle soreness in mice: Targeting peripheral and spinal cord nociceptive mechanisms

Sergio M. Borghi, Tiago H. Zaninelli, Telma Saraiva-Santos, Mariana M. Bertozzi, Renato D. R. Cardoso, Thacyana T. Carvalho, Camila R. Ferraz, Doumit Camilios-Neto, Fernando Q. Cunha, Thiago M. Cunha, Felipe A. Pinho-Ribeiro, Rubia Casagrande, Waldiceu A. Verri

Summary: In this study, the researchers investigated the effect of pentoxifylline (Ptx) on delayed-onset muscle soreness (DOMS) in untrained mice exposed to intense acute swimming exercise. They found that Ptx treatment reduced mechanical hyperalgesia caused by intense acute swimming in a dose-dependent manner. Ptx also inhibited neutrophil recruitment, oxidative stress, and cytokine production in the muscle tissue and spinal cord, as well as reduced glial cell activation in the spinal cord. These findings suggest that Ptx can alleviate pain in DOMS by targeting peripheral and spinal cord mechanisms.

FRONTIERS IN PHARMACOLOGY (2023)

Article Cell Biology

Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients

N. B. Amaral, T. S. Rodrigues, M. C. Giannini, M. I. Lopes, L. P. Bonjorno, P. I. S. O. Menezes, S. M. Dib, S. L. G. Gigante, M. N. Benatti, U. C. Rezek, L. L. Emrich-Filho, B. A. Sousa, S. C. L. Almeida, R. Luppino-Assad, F. P. Veras, A. H. Schneider, L. O. S. Leiria, L. D. Cunha, J. C. Alves-Filho, T. M. Cunha, E. Arruda, C. H. Miranda, A. Pazin-Filho, M. Auxiliadora-Martins, M. C. Borges, B. A. L. Fonseca, V. R. Bollela, C. M. Del-Ben, F. Q. Cunha, R. C. Santana, F. C. Vilar, D. S. Zamboni, P. Louzada-Junior, R. D. R. Oliveira

Summary: This study evaluated whether colchicine treatment was associated with the inhibition of NLRP3 inflammasome activation in patients with COVID-19. The results showed that colchicine reduced the need for supplemental oxygen and the length of hospitalization, and lowered the serum levels of Casp1p20 and IL-18 in the first two days of treatment.

INFLAMMATION RESEARCH (2023)

Article Immunology

CASP4/11 Contributes to NLRP3 Activation and COVID-19 Exacerbation

Tamara S. Rodrigues, Camila C. S. Caetano, Keyla S. G. de Sa, Leticia Almeida, Amanda Becerra, Augusto Goncalves, Leticia de Sousa Lopes, Samuel Oliveira, Danielle P. A. Mascarenhas, Sabrina S. Batah, Bruna M. Silva, Giovanni F. Gomes, Ricardo Castro, Ronaldo B. Martins, Jonathan Avila, Fabiani G. Frantz, Thiago M. Cunha, Eurico Arruda, Fernando Q. Cunha, Helder Nakaya, Larissa D. Cunha, Alexandre T. Fabro, Paulo Louzada-Junior, Rene D. R. de Oliveira, Dario S. Zamboni

Summary: SARS-CoV-2 infection activates the NLRP3 inflammasome and leads to inflammation and severe COVID-19. Human caspase-4 (mouse caspase-11) is upregulated and activated by SARS-CoV-2, contributing to NLRP3 activation. In vivo studies using transgenic hACE2 humanized mice show that hACE2 Casp11(-/-) mice are protected from disease development, with reduced lung damage, clinical symptoms, and mortality. Analysis of human samples from fatal COVID-19 cases reveals the expression of CASP4 in patient lungs, which correlates with inflammasome components and inflammatory mediators. These findings suggest CASP4/11 as a potential target for therapeutic interventions in COVID-19.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Biochemistry & Molecular Biology

Effects of C-Terminal-Ethyl-Esterification in a Snake-Venom-Based Peptide Against the Neurotoxicity of Acrolein in PC12 Cells

Carolina P. Bernardes, Neife A. G. Santos, Tassia R. Costa, Danilo L. Menaldo, Flavia M. Sisti, Martin K. Amstalden, Diego L. Ribeiro, Lusania M. G. Antunes, Suely V. Sampaio, Antonio C. Santos

Summary: In this study, the snake-venom-based tripeptide BTX-I was chemically modified to enhance its neurotrophic and neuroprotective effects. The ethyl-esterified peptide BTX-II showed significant improvement in promoting neuritogenesis and upregulating proteins and genes associated with cognitive improvements.

INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2023)

Article Respiratory System

Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model

Flavio P. Veras, Giovanni F. Gomes, Bruna M. S. Silva, Diego B. Caetite, Cicero J. L. R. Almeida, Camila Meirelles S. Silva, Ayda H. Schneider, Emily S. Corneo, Caio S. Bonilha, Sabrina S. Batah, Ronaldo Martins, Eurico Arruda, Alexandre T. Fabro, Jose C. Alves-Filho, Thiago M. Cunha, Fernando Q. Cunha

Summary: COVID-19 is characterized by severe lung injury due to neutrophil infiltration and release of neutrophil extracellular traps (NETs). This study demonstrates that treatment with DNase I, which degrades NETs, improves clinical symptoms and reduces lung, heart, and kidney injuries in a COVID-19 mouse model.

RESPIRATORY RESEARCH (2023)

Article Multidisciplinary Sciences

Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon

Tristram A. J. Ryan, Alexander Hooftman, Aisling M. Rehill, Matt D. Johansen, Eoin C. O'Brien, Juliana E. Toller-Kawahisa, Mieszko M. Wilk, Emily A. Day, Hauke J. Weiss, Pourya Sarvari, Emilio G. Vozza, Fabian Schramm, Christian G. Peace, Alessia Zotta, Stefan Miemczyk, Christina Nalkurthi, Nicole G. Hansbro, Gavin McManus, Laura O'Doherty, Siobhan Gargan, Aideen Long, Jean Dunne, Cliona Ni Cheallaigh, Niall Conlon, Michael Carty, Padraic G. Fallon, Kingston H. G. Mills, Emma M. Creagh, James S. O'Donnell, Paul J. Hertzog, Philip M. Hansbro, Rachel M. McLoughlin, Malgorzata Wygrecka, Roger J. S. Preston, Zbigniew Zaslona, Luke A. J. O'Neill

Summary: Excessive inflammation-associated coagulation is a major cause of mortality in infectious diseases. Recent research has found that type I interferon signaling is necessary for the release of tissue factor, a critical initiator of coagulation, providing an important link between innate immunity and coagulation. DMF and 4-OI inhibit tissue factor-mediated coagulopathy through suppression of macrophage type I IFN-TF axis.

NATURE COMMUNICATIONS (2023)

Correction Biochemistry & Molecular Biology

miR-196a provides antioxidative neuroprotection via USP15/Nrf2 regulation in Huntington's disease (vol 209, pg 292, 2023)

Siew Chin Chan, Chih-Wei Tung, Chia-Wei Lin, Yun-Shiuan Tung, Po-Min Wu, Pei-Hsun Cheng, Chuan-Mu Chen, Shang-Hsun Yang

FREE RADICAL BIOLOGY AND MEDICINE (2024)

Article Biochemistry & Molecular Biology

Ribosome-targeting antibiotic control NLRP3-mediated inflammation by inhibiting mitochondrial DNA synthesis

Suyuan Liu, Meiling Tan, Jiangxue Cai, Chenxuan Li, Miaoxin Yang, Xiaoxiao Sun, Bin He

Summary: This study reveals that the antibiotic doxycycline effectively inhibits NLRP3 inflammasome activation by targeting mitochondrial translation and mtDNA synthesis, offering potential for the treatment of NLRP3-related diseases.

FREE RADICAL BIOLOGY AND MEDICINE (2024)

Article Biochemistry & Molecular Biology

Protectin D1 inhibits TLR4 signaling pathway to alleviate non-alcoholic steatohepatitis via upregulating IRAK-M

Hao Liu, Nana Li, Ge Kuang, Xia Gong, Ting Wang, Jun Hu, Hui Du, Minxuan Zhong, Jiashi Guo, Yao Xie, Yang Xiang, Shengwang Wu, Yiling Yuan, Xinru Yin, Jingyuan Wan, Ke Li

Summary: Protectin D1 (PTD1) improves hepatic steatosis, inflammation and fibrosis in a NASH mouse model by inhibiting the activation of TLR4 downstream signaling pathway, possibly through upregulation of IRAK-M expression, suggesting a potential new treatment for NASH.

FREE RADICAL BIOLOGY AND MEDICINE (2024)